Monica Forbes
Corporate Officer/Principal bij APOGEE THERAPEUTICS, INC.
Vermogen: 33 626 $ op 31-05-2024
Actieve functies van Monica Forbes
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
APOGEE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-05-2023 | - |
Loopbaan van Monica Forbes
Eerdere bekende functies van Monica Forbes
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CARISMA THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-08-2019 | 07-03-2023 |
Treasurer | - | 07-03-2023 | |
Nalpropion Pharmaceuticals, Inc.
Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Financieel Directeur/CFO | 01-07-2018 | 01-04-2019 |
OREXIGEN THERAPEUTICS, INC. | Financieel Directeur/CFO | 24-02-2018 | 27-07-2018 |
Corporate Officer/Principal | 01-10-2014 | 24-02-2018 |
Opleiding van Monica Forbes
San Diego State University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Operationeel
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
APOGEE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Orexigen Therapeutics, Inc.
Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Nalpropion Pharmaceuticals, Inc.
Nalpropion Pharmaceuticals, Inc. Managed Health CareHealth Services Nalpropion Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the treatment of weight loss. Its products include CONTRAVE, analtrexone HCl & bupropion HCl extended release and Mysimba, a naltrexone HCl/ bupropion HCl prolonged release. The company is headquartered in Morristown, NJ. | Health Services |
- Beurs
- Insiders
- Monica Forbes
- Ervaring